All Articles

Unique AI’s launch of persistent memory agents signals a shift in financial services, moving beyond generic chatbots to secure, compliant digital teammates.

Shell’s acquisition of a 30% stake in the Bay du Nord project signals a pragmatic shift, prioritizing high-margin deepwater oil despite net-zero pressures.

For decades, severe acne treatments forced patients into a maze of antibiotics and harsh side effects. A new drug might finally change the system.

As Tejas Networks and Qualcomm unveil 6G ISAC technology, we must ask: what happens when our telecom infrastructure doubles as a pervasive surveillance grid?

As Hisense launches its PureSmart Duo refrigerator, the tech giant is using its display dominance to turn the kitchen into a high-stakes data ecosystem.

A new alliance between QAD | Redzone and PwC Belgium aims to cure digital transformation fatigue by pairing AI tools with human-centric change management.

As Anthony Vaccarello steps down from Saint Laurent, Kering faces a high-stakes transition. Who will inherit the iconic French house's rock-and-roll legacy?

A new proof-of-concept from HSBC and Ant Digital Technologies shows how autonomous AI agents can execute regulated micropayments using tokenised deposits.

Crescent Energy's $1 billion stock offering, heavily anchored by KKR, reveals a structural shift in how North American shale consolidation is financed.

As bird-safe mandates and energy codes reshape American skylines, Turkish industrial giant Sisecam aims to build the sustainable facades of tomorrow.

As global supply chains fracture, Chinese manufacturers are flocking to Uzbekistan's textile fairs to build a new Silk Road manufacturing powerhouse.

NW Natural Holdings just secured its 71st year of dividend hikes. A forensic look at how Texas gas and water acquisitions are fueling the historic payout.

Despite classic late-cycle warnings, UOB Asset Management's Q4 strategy favors US tech and Asian semiconductors while shunning traditional fixed income.

As The Business Times launches an exclusive luxury symposium, the move highlights Singapore's shift from passive wealth hub to global tastemaker.

By collapsing three Lincoln Center concepts into one, Daniel Boulud proves that surviving NYC's dining scene requires ruthless operational efficiency.

With new Phase 3 data for inactive thyroid eye disease, Innovent Biologics is solidifying a domestic moat against foreign biotech rivals in China.

From Haiti to Qatar, the 2027 ACGME-I Awards honor the educators and administrators sustaining world-class medical residency training amid global challenges.

Singapore's Basel Medical Group prices a highly dilutive $7.98 million offering, expanding its share count by nearly 400% to secure immediate Nasdaq liquidity.

A landmark 6,000-person trial by Holobiome and Radicle Science is utilizing AI and decentralized testing to see if food can solve anxiety.

By bypassing the blood-brain barrier, AviadoBio's novel gene therapy halts key neurodegeneration markers in a devastating form of genetic dementia.